The alchemy of precision and innovation: treating chronic airway inflammatory conditions in 2025.

IF 4.8 2区医学 Q1 OTORHINOLARYNGOLOGY

Rhinology Pub Date : 2025-04-01 DOI:10.4193/Rhin25.902

M B Soyka

引用次数: 0

Abstract

Chronic inflammatory processes of the upper and lower airways can represent a nightmare for both the treating physician as well as suffering patients. The advent of biologicals and use of personalized medicine has revolutionized its management in many ways, still leaving unresolved gaps that need to be closed with innovative approaches and proof of efficacy in everyday life.

查看原文本刊更多论文

精准与创新的炼金术：2025年治疗慢性气道炎症。

上呼吸道和下呼吸道的慢性炎症过程对治疗医生和患者来说都是一场噩梦。生物制剂的出现和个性化医疗的使用在许多方面彻底改变了其管理，但仍然存在未解决的差距，需要通过创新的方法和在日常生活中的有效性证明来弥补(1)。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Rhinology 医学-耳鼻喉科学

CiteScore

15.80

自引率

9.70%

发文量

135

审稿时长

6-12 weeks

期刊介绍： Rhinology serves as the official Journal of the International Rhinologic Society and is recognized as one of the journals of the European Rhinologic Society. It offers a prominent platform for disseminating rhinologic research, reviews, position papers, task force reports, and guidelines to an international scientific audience. The journal also boasts the prestigious European Position Paper in Rhinosinusitis (EPOS), a highly influential publication first released in 2005 and subsequently updated in 2007, 2012, and most recently in 2020. Employing a double-blind peer review system, Rhinology welcomes original articles, review articles, and letters to the editor.